Exelixis Inc. Common Stock vs Rubrik Inc. Class A Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while Rubrik Inc. Class A Common Stock trades at $125.14 (market cap $25.06B). The key difference: Rubrik Inc. Class A Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is more actively traded (2,684,957 versus 2,394,852). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Rubrik Inc. Class A Common Stock for 1 Days on average.
| EXEL | RBRK | |
|---|---|---|
Market Cap | $14.62B | $25.06B |
Volume | 2,684,957 | 2,394,852 |
Sector | Health | Technology |
52-Week High | $59.13 | $125.80 |
52-Week Low | $34.54 | $43.81 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $24.46B |
Trailing returns across standard periods
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Rubrik provides data security and cyber recovery software for enterprises. Its platform protects data across on-premises, cloud, SaaS, and unstructured-data environments.
Read more on RBRK →